Literature DB >> 18420937

The antidepressant fluoxetine restores plasticity in the adult visual cortex.

José Fernando Maya Vetencourt1, Alessandro Sale, Alessandro Viegi, Laura Baroncelli, Roberto De Pasquale, Olivia F O'Leary, Eero Castrén, Lamberto Maffei.   

Abstract

We investigated whether fluoxetine, a widely prescribed medication for treatment of depression, restores neuronal plasticity in the adult visual system of the rat. We found that chronic administration of fluoxetine reinstates ocular dominance plasticity in adulthood and promotes the recovery of visual functions in adult amblyopic animals, as tested electrophysiologically and behaviorally. These effects were accompanied by reduced intracortical inhibition and increased expression of brain-derived neurotrophic factor in the visual cortex. Cortical administration of diazepam prevented the effects induced by fluoxetine, indicating that the reduction of intracortical inhibition promotes visual cortical plasticity in the adult. Our results suggest a potential clinical application for fluoxetine in amblyopia as well as new mechanisms for the therapeutic effects of antidepressants and for the pathophysiology of mood disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420937     DOI: 10.1126/science.1150516

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  346 in total

1.  Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex.

Authors:  José Fernando Maya-Vetencourt; Ettore Tiraboschi; Dario Greco; Laura Restani; Chiara Cerri; Petri Auvinen; Lamberto Maffei; Eero Castrén
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

Review 2.  Structural plasticity upon learning: regulation and functions.

Authors:  Pico Caroni; Flavio Donato; Dominique Muller
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

3.  Reversal of hippocampal neuronal maturation by serotonergic antidepressants.

Authors:  Katsunori Kobayashi; Yumiko Ikeda; Atsushi Sakai; Nobuyuki Yamasaki; Eisuke Haneda; Tsuyoshi Miyakawa; Hidenori Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram.

Authors:  Naseema Cassimjee; Jean-Pierre Fouche; Michael Burnett; Christine Lochner; James Warwick; Patrick Dupont; Dan J Stein; Karen J Cloete; Paul D Carey
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

5.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

6.  Paradoxical Motor Recovery From a First Stroke After Induction of a Second Stroke: Reopening a Postischemic Sensitive Period.

Authors:  Steven R Zeiler; Robert Hubbard; Ellen M Gibson; Tony Zheng; Kwan Ng; Richard O'Brien; John W Krakauer
Journal:  Neurorehabil Neural Repair       Date:  2015-12-31       Impact factor: 3.919

7.  Neuronal plasticity and antidepressant actions.

Authors:  Eero Castrén; René Hen
Journal:  Trends Neurosci       Date:  2013-02-01       Impact factor: 13.837

8.  Activation of serotonin 3 receptors changes in vivo auditory responses in the mouse inferior colliculus.

Authors:  Alexander Bohorquez; Laura M Hurley
Journal:  Hear Res       Date:  2009-02-21       Impact factor: 3.208

9.  A theory of the transition to critical period plasticity: inhibition selectively suppresses spontaneous activity.

Authors:  Taro Toyoizumi; Hiroyuki Miyamoto; Yoko Yazaki-Sugiyama; Nafiseh Atapour; Takao K Hensch; Kenneth D Miller
Journal:  Neuron       Date:  2013-10-02       Impact factor: 17.173

10.  Rethinking amblyopia 2020.

Authors:  Dennis M Levi
Journal:  Vision Res       Date:  2020-08-28       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.